Your selection
Research / 29.08.2025
Professorship awarded to Ashley Sanders
Ashley Sanders has been awarded a full professorship from Charité –Universitätsmedizin Berlin. The tenured position will enable her and her team to expand their research on developing personalized therapies for inflammatory bowel disease and other conditions.
Dr. Ashley Sanders, Group Leader of the Genome Instability and Somatic Mosaicism lab at the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB), has been awarded a W3 professorship from Charité – Universitätsmedizin Berlin in the Faculty of Medicine. This prestigious recognition honors Sanders’contributions to the field of single-cell DNA sequencing, where she has helped redefine our understanding of genomic structure and variability.
“The professorship is a complete game-changer for me and my team,” says Sanders, who has been a junior group leader at the Max Delbrück Center since only 2021.
Through her research, Sanders has expanded the scope of single-cell genomics beyond RNA analysis to include DNA. She helped develop Strand-seq, a technique that enables scientists to detect structural variants – such as inversions, duplications, and deletions – in the DNA of individual cells. Her work has revealed that that somatic genomic mosaicism is more common than previously thought – challenging the longstanding assumption that all cells in a person’s body share an identical DNA sequence. Moreover, Sanders’ research suggests that structural variation in our cellular DNA may contribute to the development cancer, inflammatory bowel and autoimmune diseases. Such insights, she hopes, will lay the groundwork for personalized medicine.
Her professorship officially begins on September 1, 2025. “It’s a tremendous honor,” Sanders says with excitement. “We now have the stability and long-term perspective to fulfill the vision we started with.”
Text: Gunjan Sinha
Further information
The pioneer of single cell sequencing (profile of Ashley Sanders)
Overview News
News Buch Berlin
First “protein map” of neurons that initiate pain
Helmholtz researchers have created the first detailed protein map of specific sensory neurons that trigger pain. Their study, published in “Nature Communications,” will help researchers better unders...
more ...Eckert & Ziegler Secures Patient Access to Critical Eye Cancer Treatment with MDR Certification for Ru-106 Eye Applicators
Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of eye tumors and prostate cancer, obtained the MDR certificate for its Ruthenium...
more ...Gilead acquires FMP and LMU Spin-off Tubulis and expands Oncology Pipeline with next-generation ADC
U.S. biopharmaceutical company Gilead has entered into a definitive agreement to acquire Tubulis GmbH. Tubulis was spun off in 2019 from the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FM...
more ...Events Buch Berlin
16.04.2026, 09:00
Gläsernes Labor - Unsichtbare Welten: Mikroplastik in Mensch und Natur
Vorbeikommen und mitmachen: Spannende Experimentierkurse für Kids und Megamikroskopie im Zeiss-Großplanetarium
more ...16.04.2026, 09:00
Career Day 2026: “Transition Possible: Explore Careers on Campus Buch”
Are you considering your next career step as a scientist? On April 16, the Career Day at Campus Buch invites to explore possible career paths beyond academia, hearing from professionals who have made ...
more ...17.04.2026, 09:00
GOOD CLINICAL PRACTICE (GCP) - Online
Basic Training (English): The seminar will include presentations with many practical examples as well as workshops on the most important topics of GCP. The trainer will focus on the responsibilities o...
more ...